Renovate Therapeutics Ltd.
General Data
Reg Number
516566841
Sector
Biomed
Established
2022
No. of Employees
7
Stage
R&D
Additional Funding
1
Description
RenoVate Therapeutics is developing KOSEC- A novel treatment for Chronic Kidney Disease
Technology
RenoVate is developing regenerative biomolecules, aimed to repair and rejuvenate kidneys.
Targeted Customers
Kidney physicians.
Management personnel
Winning details
Route name
Winning year
Seed Investment Program
Seed Investment Program
2024
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2025